Insulet stock rises on Street-beating Q4, expected Omnipod growth

Insulet (Nasdaq:PODD) shares ticked up after market close on fourth-quarter results that came in well ahead of the consensus forecast.

Related Keywords

Massachusetts ,United States ,Acton ,Jim Hollingshead ,Massdevice Medtech , ,Wall Street ,